The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects

[1]  F. Castelló,et al.  Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders. , 2000, The American journal of clinical nutrition.

[2]  I. Mougan,et al.  Fatty Acid Composition of Human Brain Phospholipids During Normal Development , 1998, Journal of neurochemistry.

[3]  J. Janowsky,et al.  Formula Supplementation With Long-chain Polyunsaturated Fatty Acids: Are There Developmental Benefits? , 1998, Pediatrics.

[4]  B. Shatenstein,et al.  Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. , 1998, International journal of epidemiology.

[5]  S. Kish,et al.  Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type‐1 , 1998, Movement disorders : official journal of the Movement Disorder Society.

[6]  E. Lien,et al.  Docosahexaenoic acid increases thyroid-stimulating hormone concentration in male and adrenal corticotrophic hormone concentration in female weanling rats. , 1998, The Journal of nutrition.

[7]  J. Stockard,et al.  Maternal diet fatty acid composition affects neurodevelopment in rat pups. , 1998, The Journal of nutrition.

[8]  P. E. Newman.  Could diet be used to reduce the risk of developing Alzheimer's disease? , 1998, Medical hypotheses.

[9]  D. Mostofsky,et al.  Fatty Acids and Brain Peptides , 1998, Peptides.

[10]  K. Lauer.  Diet and multiple sclerosis , 1997, Neurology.

[11]  G. Anderson,et al.  Visual attention in infant monkeys: effects of dietary fatty acids and age. , 1997, Developmental psychology.

[12]  D. Kyle,et al.  Arachidonic acid offsets the effects on mouse brain and behavior of a diet with a low (n-6):(n-3) ratio and very high levels of docosahexaenoic acid. , 1997, The Journal of nutrition.

[13]  N. Auestad,et al.  Visual Acuity, Erythrocyte Fatty Acid Composition, and Growth in Term Infants Fed Formulas with Long Chain Polyunsaturated Fatty Acids for One Year , 1997, Pediatric Research.

[14]  J. Jumpsen,et al.  Lipids and Essential Fatty Acids in Brain Development , 1995 .

[15]  R. Bellù,et al.  Neurodevelopmental Quotient of Healthy Term Infants at 4 Months and Feeding Practice: The Role of Long-Chain Polyunsaturated Fatty Acids , 1995, Pediatric Research.

[16]  J. Jumpsen,et al.  Brain Development: Relationship to Dietary Lipid and Lipid Metabolism , 1995 .

[17]  K. Beckman,et al.  Very long chain fatty acids in X‐linked adrenoleukodystrophy brain after treatment with Lorenzo's oil , 1994, Annals of neurology.

[18]  Z. Guan,et al.  Content and fatty acid composition of cardiolipin in the brain of patients with alzheimer's disease , 1994, Neurochemistry International.

[19]  C. Adamsbaum,et al.  A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy. , 1993, The New England journal of medicine.

[20]  C. Hutter.  On the causes of multiple sclerosis. , 1993, Medical hypotheses.

[21]  J. Sargent,et al.  Lipid and Fatty Acid Composition of Brain Tissue from Adrenoleukodystrophy Patients , 1993, Journal of neurochemistry.

[22]  J. Besson,et al.  Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. , 1993, Brain : a journal of neurology.

[23]  F. Skovby,et al.  Postmortem findings and prenatal diagnosis of Zellweger syndrome , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[24]  G. Durand,et al.  Function of dietary polyunsaturated fatty acids in the nervous system. , 1993, Prostaglandins, leukotrienes, and essential fatty acids.

[25]  S. Coppack,et al.  Effect of diet on human adipose tissue metabolism , 1992, Proceedings of the Nutrition Society.

[26]  D. Je.  Diet and body lipid composition: lessons from animal and human experiments. , 1992 .

[27]  J. Viikari,et al.  Correlation of serum fatty acid composition with dietary intake data in children and young adults. , 1992, Annals of medicine.

[28]  D. Johnson,et al.  Very long-chain fatty acids in peroxisomal disease. , 1992, Advances in experimental medicine and biology.

[29]  D. Johnson,et al.  Molecular Species of Phosphatidylcholine Containing Very Long Chain Fatty Acids in Human Brain: Enrichment in X‐Linked Adrenoleukodystrophy Brain and Diseases of Peroxisome Biogenesis Brain , 1991, Journal of neurochemistry.

[30]  A. D. Smith,et al.  Essential fatty acids in membrane: physical properties and function. , 1990, Biochemical Society transactions.

[31]  K. Hargreaves,et al.  Dietary lipids in relation to postnatal development of the brain. , 1990, Upsala journal of medical sciences. Supplement.

[32]  W. Rizzo,et al.  Dietary erucic acid therapy for X‐linked adrenoleukodystrophy , 1989, Neurology.

[33]  M. Crawford,et al.  The effect of nutritional counselling on diet and plasma EFA status in multiple sclerosis patients over 3 years. , 1987, Human nutrition. Applied nutrition.

[34]  D. S. Lin,et al.  Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  F. Rocchiccioli,et al.  The cerebro-hepato-renal (Zellweger) syndrome: Lamellar lipid profiles in adrenocortical, hepatic mesenchymal, astrocyte cells and increased levels of very long chain fatty acids and phytanic acid in the plasma , 1985, Journal of the Neurological Sciences.

[36]  L. Gershbein,et al.  Regression analysis of total fatty acids from human whole brain according to age and sex. , 1985, Journal of applied biochemistry.

[37]  H. Moser,et al.  Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids. , 1982, The Johns Hopkins medical journal.

[38]  R. C. Johnson,et al.  Fatty acid composition of lipids in cerebral myelin and synaptosomes in phenylketonuria and Down syndrome. , 1977, Archives of neurology.

[39]  P. Schreibman.  Diet and plasma lipids. , 1975, Advances in experimental medicine and biology.

[40]  L. Eng,et al.  Lipid alterations in human brains in phenylketonuria , 1967, Neurology.